Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease

OBJECTIVE: To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson’s disease (PD). BACKGROUND: Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect sleep, little is known about the effects of sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Taguchi, Soutarou, Koide, Hirofumi, Oiwa, Hiroko, Hayashi, Miku, Ogawa, Kazuhiro, Ito, Chihiro, Nakashima, Koji, Yuasa, Tomoko, Yasumoto, Akihiro, Ando, Hiroaki, Fujikake, Akifumi, Fukuoka, Takaaki, Tokui, Keisuke, Izumi, Masayuki, Tsunoda, Yuka, Kawagashira, Yuichi, Okada, Yohei, Niwa, Jun-ichi, Doyu, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318227/
https://www.ncbi.nlm.nih.gov/pubmed/34320022
http://dx.doi.org/10.1371/journal.pone.0255274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318227/
https://www.ncbi.nlm.nih.gov/pubmed/34320022
http://dx.doi.org/10.1371/journal.pone.0255274

Ejemplares similares